Cationorm – a preservative-free dry eye treatment

Cationorm (cationic nanoemulsion) is a  preservative-free, hydrating and lubricating emulsion which protects the eye surface, reducing the discomfort and irritation of persistent dry eye caused by prolonged use of contact lenses, or environmental conditions.¹

The therapy’s triple action repairs the lipid layer to reduce evaporation, lubricate and stabilise the tear film; restores the balance of moisture in the muco-aqueous layer of the tear film; and is positively attracted to the ocular surface, to provide long-lasting protection.^2-5

Cationorm is suitable for use with contact lenses, and is conveniently delivered via a preservative free, multi-dose bottle, or single dose ampoules.⁶

It can be administered as one drop, up to four times daily in the affected eye(s).⁶

ALWAYS FOLLOW THE DIRECTIONS FOR USE. IF SYMPTOMS PERSIST, TALK TO YOUR HEALTH PROFESSIONAL.

To order Cationorm, contact Good Optical Services: 1800 814 963 or orders@goodopticalservices.com.au

For more information, contact Seqirus Medical Information: 1800 642 865 or aunz.medicalinformation@seqirus.com.

References

1. Therapeutic Goods Administration. Australian Register of Therapeutic Goods – Public Summary Seqirus PTY LTD – Lubricant, eye. [cited 2021; Available from: https://www.ebs.tga.gov.au/servlet/xmlmillr6?dbid=ebs/PublicHTML/pdfStore.nsf&docid=406945E40B6D2CA4CA25843C0042145B&agid=(PrintDetailsPublic)&actionid=1.
2. Lallemand, F., et al., Successfully improving ocular drug delivery using the cationic nanoemulsion, novasorb. J Drug Deliv, 2012. 2012: p. 604204.
3. Daull, P., F. Lallemand, and J.S. Garrigue, Benefits of cetalkonium chloride cationic oil-in-water nanoemulsions for topical ophthalmic drug delivery. J Pharm Pharmacol, 2014. 66(4): p. 531-41.
4. Amrane, M., et al., Ocular tolerability and efficacy of a cationic emulsion in patients with mild to moderate dry eye disease – a randomised comparative study. J Fr Ophtalmol, 2014. 37(8): p. 589-98.
5. Robert, P.Y., et al., Efficacy and safety of a cationic emulsion in the treatment of moderate to severe dry eye disease: a randomized controlled study. Eur J Ophthalmol, 2016. 26(6): p. 546-555.
6. Cationorm product package.